Clinical improvement in a patient with monostotic melorheostosis after treatment with denosumab: a case reportEffects of anti-osteoporosis medications on fracture healingEffects of increasing age, dosage, and duration of PTH treatment on BMD increase--a meta-analysis.Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis.Effects of treatment with fluoride on bone mineral density and fracture risk--a meta-analysis.Elevated liver enzymes, anaemia and osteopaenia in a young womanErratum to: determinants of vitamin D status in young adults: influence of lifestyle, sociodemographic and anthropometric factors.Non-infectious osteomyelitis of the mandible in a young woman: a case reportParathyroid hormone and bone healingParathyroid hormone dynamics in vivo.Role of purinergic receptor polymorphisms in human bone.The calcium-sensing receptor in human disease.The P2X7 receptor: a key player in immune-mediated bone loss?[Bone metabolism and physical training][Calcium homeostasis and normal bone remodeling].[Calcium homeostasis][Diphosphonate treatment of osteoporosis and risk of atypical femoral fractures][Investigation and diagnosis of familial hypocalciuric hypercalcemia in Denmark].[Osteoporosis often occurs in Parkinson's disease patients][Physical activity and chronic disease I. Heart disease and hypertension][Physical activity and chronic disease II. Type 2 diabetes, obesity and cancer][Physical activity and chronic disease III. Musculoskeletal diseases and lung diseases][Primary hyperparathyroidism--occurrence, symptoms, complications and treatment][SERM--selective estrogen receptor modulators]
author
gender
type
comment
hulumtues
@sq
researcher
@en
wetenschapper
@nl
дослідник
@uk
հետազոտող
@hy
গবেষক
@bn
ഗവേഷകൻ
@ml
研究者
@ja
研究者
@zh
연구원
@ko
label
Peter Schwarz
@ast
Peter Schwarz
@en
Peter Schwarz
@es
Peter Schwarz
@it
Peter Schwarz
@nl
Peter Schwarz
@sl